Nicorama Mint (Nicotine)

Nicotine, the active ingredient in Nicorama Mint, is a nicotinic receptor agonist presented as an oral formulation for oral use. It treats nicotine dependence and aids smoking cessation in adults.

GNH USA supplies Nicorama Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine is used in smoking cessation, targeting the nicotinic acetylcholine receptor pathway.

- Smoking cessation: helps reduce withdrawal symptoms and cravings associated with nicotine dependence. - Nicotine dependence: supports adults who wish to quit tobacco use by mitigating cravings. - Tobacco use disorder: assists in managing the physiological aspects of quitting.

Common Side Effects: - Nausea: mild stomach discomfort after oral administration. - Mouth irritation: tingling or soreness in the oral cavity. - Hiccups: transient episodes following dosing. - Dizziness: light‑headed sensation, especially on first use. - Headache: mild to moderate tension‑type pain. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Arrhythmia: irregular heart rhythm requiring medical attention. - Severe hypertension: marked increase in blood pressure. - Allergic reaction: rash, swelling, or difficulty breathing. - Seizure: rare convulsive episodes. - Chest pain: possible indication of cardiac stress. - Anaphylaxis: life‑threatening systemic reaction.

Before using Nicorama Mint, consider the following precautions. - Cardiovascular assessment: evaluate blood pressure and heart rhythm. - Medical supervision: use under guidance of a healthcare professional. - Hypertension avoidance: do not use in uncontrolled high blood pressure. - Non‑smoker restriction: not indicated for individuals who do not use tobacco. - Dependence monitoring: watch for continued nicotine reliance. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Nicotine may interact with several medicines; review the following.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: can amplify sympathomimetic effects. - Insulin: nicotine may affect glucose control. - Warfarin: potential alteration of anticoagulant activity.

Moderate Interactions (Monitor Closely): - Caffeine: additive stimulant effects may increase jitteriness. - Alcohol: combined use can enhance cardiovascular strain. - Selective serotonin reuptake inhibitors: may require dose adjustments due to metabolic pathways.